Gsk (GSK) Net Income - Minority (2016 - 2025)
Historic Net Income - Minority for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to -$21.8 billion.
- Gsk's Net Income - Minority fell 1969.07% to -$21.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.8 billion, marking a year-over-year decrease of 1969.07%. This contributed to the annual value of -$17.5 billion for FY2024, which is 526.46% down from last year.
- According to the latest figures from Q3 2025, Gsk's Net Income - Minority is -$21.8 billion, which was down 1969.07% from -$19.7 billion recorded in Q2 2025.
- Gsk's Net Income - Minority's 5-year high stood at -$10.8 billion during Q3 2022, with a 5-year trough of -$21.8 billion in Q3 2025.
- For the 5-year period, Gsk's Net Income - Minority averaged around -$18.2 billion, with its median value being -$18.2 billion (2024).
- As far as peak fluctuations go, Gsk's Net Income - Minority surged by 4928.03% in 2022, and later crashed by 3326.41% in 2023.
- Quarter analysis of 5 years shows Gsk's Net Income - Minority stood at -$20.3 billion in 2021, then skyrocketed by 38.75% to -$12.4 billion in 2022, then plummeted by 33.26% to -$16.6 billion in 2023, then fell by 5.92% to -$17.5 billion in 2024, then decreased by 24.15% to -$21.8 billion in 2025.
- Its Net Income - Minority was -$21.8 billion in Q3 2025, compared to -$19.7 billion in Q2 2025 and -$17.8 billion in Q1 2025.